| 臺大學術典藏 |
2021-05-31T07:12:32Z |
Purification and characterization of a platelet aggregation inducer from Calloselasma rhodostoma (Malayan pit viper) snake venom
|
Ouyang C.; Yeh H.-I.; TUR-FU HUANG |
| 臺大學術典藏 |
2021-05-31T07:03:16Z |
Butein inhibits angiogenesis of human endothelial progenitor cells via the translation dependent signaling pathway
|
Chung C.-H.; Chang C.-H.; Chen S.-S.; Wang H.-H.; Yen J.-Y.; Hsiao C.-J.; Wu N.-L.; Chen Y.-L.; TUR-FU HUANG; Wang P.-C.; Yeh H.-I.; Wang S.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:28Z |
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan
|
Ho L.-T.; Yin W.-H.; Chuang S.-Y.; Tseng W.-K.; YEN-WEN WU; Hsieh I.-C.; Lin T.-H.; Li Y.-H.; Huang L.-C.; Wang K.-Y.; Ueng K.-C.; Fang C.-C.; Pan W.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:19Z |
Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:17Z |
Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease
|
Chien S.-C.; Chen C.-Y.; Leu H.-B.; Su C.-H.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Yeh H.-I.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:16Z |
Optimal achieved blood pressure for patients with stable coronary artery disease
|
Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:16Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:15Z |
2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang C.-E.; Lin S.-Y.; Lin T.-H.; Wang T.-D.; Yeh H.-I.; Chen J.-F.; Tsai C.-T.; Hung Y.-J.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Wang K.-L.; Chao T.-H.; Shyu K.-G.; Yang W.-S.; Ueng K.-C.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Cheng H.-M.; Shin S.-J.; Huang C.-N.; Chuang L.-M.; Lin S.-J.; Yeh S.-J.; Sheu W.H.-H.; Lin J.-L. |
| 臺大學術典藏 |
2021-03-18T08:54:13Z |
The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
|
Ho S.-K.; YEN-WEN WU; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:13Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; YEN-WEN WU; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:11Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; YEN-WEN WU; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C. |
| 臺大學術典藏 |
2021-03-18T08:54:09Z |
Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Cheng Chang K.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:08Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Hsu C.-Y.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; Wu C.-C.; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:05Z |
Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x)
|
Ho S.-K.; YEN-WEN WU; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:05Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Wu J.-R.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:02Z |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang C.-E.; Ueng K.-C.; Chao T.-H.; Lin T.-H.; Wu Y.-J.; Wang K.-L.; Sung S.-H.; Yeh H.-I.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Shyu K.-G.; Huang J.-L.; Tsai C.-D.; Hung H.-F.; Liu M.-E.; Chao T.-F.; Cheng S.-M.; Cheng H.-M.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Chen W.-J.; Lai W.-T.; Lin S.-J.; Yeh S.-J.; Hwang J.-J. |
| 臺大學術典藏 |
2021-03-18T08:54:02Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; YEN-WEN WU; Hwang J.-J.; Lin J.-L. |
| 臺大學術典藏 |
2021-03-18T08:54:01Z |
Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease
|
YEN-WEN WU; Ho S.K.; Tseng W.-K.; Yeh H.-I.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:01Z |
Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease
|
Huang C.-C.; Chang M.-T.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Shyur L.-F.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:00Z |
Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions
|
Tsai H.-Y.; YEN-WEN WU; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W.; Yeh H.-I.; National Taiwan Biosignature Research Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:00Z |
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
|
Li Y.-H.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; YEN-WEN WU; Hsieh I.-C.; Lin T.-H.; Sheu W.H.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T08:53:59Z |
Sex, racial differences and healthy aging in normative reference ranges on diastolic function in Ethnic Asians: 2016 ASE guideline revisited
|
Chang S.-N.; Sung K.-T.; Huang W.-H.; Lin J.-W.; Chien S.-C.; Hung T.-C.; Su C.-H.; Hung C.-L.; Tsai C.-T.; YEN-WEN WU; Chiang F.-T.; Yeh H.-I.; Hwang J.-J. |
| 臺大學術典藏 |
2021-03-11T04:30:13Z |
Temporal changes in cardiac force- and flow-generation capacity, loading conditions, and mechanical efficiency in streptozotocin-induced diabetic rats
|
Yeih D.-F.;Lin L.-Y.;Yeh H.-I.;Lai Y.-J.;Fu-Tien Chiang;Tseng C.-D.;Chu S.-H.;Tseng Y.-Z.; Yeih D.-F.; Lin L.-Y.; Yeh H.-I.; Lai Y.-J.; FU-TIEN CHIANG; Tseng C.-D.; Chu S.-H.; Tseng Y.-Z. |
| 臺大學術典藏 |
2021-03-11T04:30:00Z |
Dimethylthiourea normalizes velocity-dependent, but not force-dependent, index of ventricular performance in diabetic rats: Role of myosin heavy chain isozyme
|
Yeih D.-F.; Yeh H.-I.; Hsin H.-T.; Lin L.-Y.; FU-TIEN CHIANG; Tseng C.-D.; Chu S.-H.; Tseng Y.-Z. |
| 臺大學術典藏 |
2021-03-11T04:29:56Z |
2010 Guidelines of the Taiwan society of cardiology for the management of hypertension
|
Chiang C.-E.;Wang T.-D.;Li Y.-H.;Lin T.-H.;Chien K.-L.;Yeh H.-I.;Shyu K.-G.;Tsai W.-C.;Chao T.-H.;Hwang J.-J.;Fu-Tien Chiang;Chen J.-H.; Chiang C.-E.; Wang T.-D.; Li Y.-H.; Lin T.-H.; Chien K.-L.; Yeh H.-I.; Shyu K.-G.; Tsai W.-C.; Chao T.-H.; Hwang J.-J.; FU-TIEN CHIANG; Chen J.-H. |
